Detalhe da pesquisa
1.
A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide.
Prostate
; 83(4): 376-384, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564933
2.
Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).
Curr Oncol Rep
; 18(12): 72, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27812861
3.
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.
Clin Genitourin Cancer
; 21(3): e166-e174, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36610891
4.
Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus.
Clin Transl Oncol
; 24(8): 1515-1523, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349041
5.
SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021).
Clin Transl Oncol
; 24(4): 613-624, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347572
6.
Molecular basis of hypertension side effects induced by sunitinib.
Anticancer Drugs
; 22(1): 1-8, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20938340
7.
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
Target Oncol
; 14(1): 15-32, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30694442
8.
Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.
Mol Diagn Ther
; 22(2): 169-177, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427124
9.
Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial.
Eur J Cancer
; 87: 30-37, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29102858
10.
Radium-223 dichloride: a new paradigm in the treatment of prostate cancer.
Expert Rev Anticancer Ther
; 15(3): 339-48, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25555355